Menu
GeneBe

17-63917495-A-G

Variant summary

Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS1

The NM_000515.5(GH1):c.468T>C(p.Asp156=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000154 in 1,613,968 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00015 ( 3 hom. )

Consequence

GH1
NM_000515.5 synonymous

Scores

1
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: -3.80
Variant links:
Genes affected
GH1 (HGNC:4261): (growth hormone 1) The protein encoded by this gene is a member of the somatotropin/prolactin family of hormones which play an important role in growth control. The gene, along with four other related genes, is located at the growth hormone locus on chromosome 17 where they are interspersed in the same transcriptional orientation; an arrangement which is thought to have evolved by a series of gene duplications. The five genes share a remarkably high degree of sequence identity. Alternative splicing generates additional isoforms of each of the five growth hormones, leading to further diversity and potential for specialization. This particular family member is expressed in the pituitary but not in placental tissue as is the case for the other four genes in the growth hormone locus. Mutations in or deletions of the gene lead to growth hormone deficiency and short stature. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.013378203).
BP6
Variant 17-63917495-A-G is Benign according to our data. Variant chr17-63917495-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 891325.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=1}.
BP7
Synonymous conserved (PhyloP=-3.8 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000177 (27/152302) while in subpopulation EAS AF= 0.000966 (5/5176). AF 95% confidence interval is 0.00038. There are 0 homozygotes in gnomad4. There are 13 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GH1NM_000515.5 linkuse as main transcriptc.468T>C p.Asp156= synonymous_variant 5/5 ENST00000323322.10
LOC112268204XR_002958148.2 linkuse as main transcriptn.341-102A>G intron_variant, non_coding_transcript_variant
GH1NM_022559.4 linkuse as main transcriptc.423T>C p.Asp141= synonymous_variant 5/5
GH1NM_022560.4 linkuse as main transcriptc.348T>C p.Asp116= synonymous_variant 4/4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GH1ENST00000323322.10 linkuse as main transcriptc.468T>C p.Asp156= synonymous_variant 5/51 NM_000515.5 P1P01241-1

Frequencies

GnomAD3 genomes
AF:
0.000171
AC:
26
AN:
152184
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.000771
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000239
AC:
60
AN:
251168
Hom.:
1
AF XY:
0.000228
AC XY:
31
AN XY:
135738
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000491
Gnomad ASJ exome
AF:
0.00188
Gnomad EAS exome
AF:
0.000544
Gnomad SAS exome
AF:
0.0000653
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.0000793
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000151
AC:
221
AN:
1461666
Hom.:
3
Cov.:
31
AF XY:
0.000166
AC XY:
121
AN XY:
727144
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.000358
Gnomad4 ASJ exome
AF:
0.00168
Gnomad4 EAS exome
AF:
0.000227
Gnomad4 SAS exome
AF:
0.000104
Gnomad4 FIN exome
AF:
0.0000749
Gnomad4 NFE exome
AF:
0.000103
Gnomad4 OTH exome
AF:
0.000364
GnomAD4 genome
AF:
0.000177
AC:
27
AN:
152302
Hom.:
0
Cov.:
32
AF XY:
0.000175
AC XY:
13
AN XY:
74482
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00173
Gnomad4 EAS
AF:
0.000966
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.000188
Gnomad4 NFE
AF:
0.000162
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000263
Hom.:
1
Bravo
AF:
0.000227
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000239
AC:
29

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingInvitaeJul 18, 2023- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenDec 01, 2022GH1: BP4, BP7 -
Decreased response to growth hormone stimulation test Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.64
Cadd
Benign
0.042
Dann
Benign
0.77
FATHMM_MKL
Benign
0.018
N
MetaRNN
Benign
0.013
T
MutationTaster
Benign
1.0
D;D;D;D;D
Sift4G
Pathogenic
0.0
D
Polyphen
0.0070
B
Vest4
0.18
MVP
0.76
GERP RS
-1.6

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201849388; hg19: chr17-61994855; API